Most of the molecular targets identified in this study are regulated by c-myc, Her2/neu, and TNF α, thus suggesting intervention of these pathways may provide a means to the development of molecular targeted therapies for endometrial cancer. This evidence concerns the gene TNF and endometrial cancer.